Identifying developmental toxicity pathways for a subset of ToxCast chemicals using human embryonic stem cells and metabolomics.
about
Review: toxicometabolomicsAssessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: the challenge aheadHuman iPSC-derived endothelial cell sprouting assay in synthetic hydrogel arraysBuilding predictive models for mechanism-of-action classification from phenotypic assay data sets.Profiling of drugs and environmental chemicals for functional impairment of neural crest migration in a novel stem cell-based test batteryPredicting the future: opportunities and challenges for the chemical industry to apply 21st-century toxicity testing.Nephron Toxicity Profiling via Untargeted Metabolome Analysis Employing a High Performance Liquid Chromatography-Mass Spectrometry-based Experimental and Computational Pipeline.A standardized human embryoid body platform for the detection and analysis of teratogensWind of change challenges toxicological regulators.Improving the human hazard characterization of chemicals: a Tox21 updateMetabolomics in toxicology and preclinical research.Mammalian cell metabolomics: experimental design and sample preparation.Stem cells and stem cell-derived tissues and their use in safety assessment.In vitro and modelling approaches to risk assessment from the U.S. Environmental Protection Agency ToxCast programme.Drug safety testing paradigm, current progress and future challenges: an overview.A critical appraisal of the process of regulatory implementation of novel in vivo and in vitro methods for chemical hazard and risk assessment.Contribution of new technologies to characterization and prediction of adverse effects.Advances in Applications of Metabolomics in Pluripotent Stem Cell Research.Removing the bottlenecks of cell culture metabolomics: fast normalization procedure, correlation of metabolites to cell number, and impact of the cell harvesting methodIn vitro acute and developmental neurotoxicity screening: an overview of cellular platforms and high-throughput technical possibilities.Alternative Models of Developmental and Reproductive Toxicity in Pharmaceutical Risk Assessment and the 3Rs.Establishment and assessment of a new human embryonic stem cell-based biomarker assay for developmental toxicity screening.Prospects and Frontiers of Stem Cell ToxicologyThe effects of triclosan on pluripotency factors and development of mouse embryonic stem cells and zebrafish.Modern methodologies and tools for human hazard assessment of chemicalsThe Opportunities of Metabolomics in Drug Safety Evaluation.An Untargeted Metabolomics Approach to Investigate the Metabolic Modulations of HepG2 Cells Exposed to Low Doses of Bisphenol A and 17β-Estradiol
P2860
Q27001191-81B9F0E1-44CF-4BA7-A0A8-69E03C9E052CQ28397132-2187CB89-3750-43B7-B78F-488DDC167025Q28397986-B1C3A8C3-9DE5-4843-ABD3-57C2052BB09BQ30671097-41AAA597-5265-42E2-8DF8-DE74D8AA6CD3Q35137761-568F6317-14EC-4164-82BE-714C67FF0FCCQ35244698-C4668930-BB0E-4A03-9D2E-4A495D9CE63BQ35905359-B82DD8A1-F7CC-4416-95DC-F078B9D09B43Q36275388-3FF855E2-F47C-4CE1-85F2-5DA0313D5D9FQ36566662-28E43214-F07C-47C2-B41A-C2E58D6D5E02Q36984065-8D52DC20-A5EE-442E-A25D-37D969AE1DB6Q37290233-F1A09AB4-5448-4830-B03C-DA6BA65C0359Q38084231-E080F53B-4BC6-4883-B4BB-19A0C1EF41D8Q38173227-3F5B94F8-0549-431F-A42F-AFE7F3AD6438Q38200703-9210D46E-9A29-4F94-A24E-4C32CA7394CCQ38207946-D0793F24-17A6-4B21-A181-D03E2C7A1059Q38233531-8A2EAB66-8AED-45B4-9420-6AB9017FBB63Q38329939-FF5CBA4B-9EFC-40D4-B35B-54C5B36E7269Q38654015-080031D1-7458-442C-91D5-EEBE58C543F3Q38741622-2D361168-7A36-492D-8856-391F45B28C74Q38753758-3536A15B-CFCA-4EAC-9BC8-84D9FC8C109BQ38774778-09F8C30A-629A-4678-8FFD-8A968D3E39B0Q39079366-2F50DCEF-DAF3-4240-9457-51410DDEEBFDQ42603119-7DCC28F8-67D5-4ABA-813D-62B50FFBE1CBQ42705494-A876E83C-7B84-4AAC-9A09-52CF690B917FQ47154406-5F066547-F7F9-41E5-83D2-9497C22A274DQ49363622-309720AE-50C8-4124-888A-298DFA548A98Q57491978-9228CBCB-5675-425E-85F4-78ACDD84D3C7
P2860
Identifying developmental toxicity pathways for a subset of ToxCast chemicals using human embryonic stem cells and metabolomics.
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Identifying developmental toxi ...... c stem cells and metabolomics.
@ast
Identifying developmental toxi ...... c stem cells and metabolomics.
@en
Identifying developmental toxi ...... c stem cells and metabolomics.
@nl
type
label
Identifying developmental toxi ...... c stem cells and metabolomics.
@ast
Identifying developmental toxi ...... c stem cells and metabolomics.
@en
Identifying developmental toxi ...... c stem cells and metabolomics.
@nl
prefLabel
Identifying developmental toxi ...... c stem cells and metabolomics.
@ast
Identifying developmental toxi ...... c stem cells and metabolomics.
@en
Identifying developmental toxi ...... c stem cells and metabolomics.
@nl
P2093
P1476
Identifying developmental toxi ...... ic stem cells and metabolomics
@en
P2093
A M Weir-Hauptman
B R Fontaine
E L R Donley
J A Palmer
K R Conard
T B Knudsen
P304
P356
10.1016/J.TAAP.2011.08.025
P577
2011-09-03T00:00:00Z